Novo Nordisk A/S ADR buy fenjal
Start price
09.05.17
/
50%
€37.03
Target price
18.09.17
€42.00
Performance (%)
10.53%
End price
18.09.17
€40.52
Summary
This prediction ended on 18.09.17 with a price of €40.52. The BUY prediction by fenjal finished with a performance of 10.53%. fenjal has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S ADR | 0.126% | 0.126% | -45.386% | -78.192% |
| iShares Core DAX® | 0.231% | -2.413% | 15.337% | 45.097% |
| iShares Nasdaq 100 | 1.663% | -1.658% | 31.087% | 76.365% |
| iShares Nikkei 225® | -0.208% | -2.502% | 43.625% | 49.585% |
| iShares S&P 500 | 1.067% | -1.579% | 24.346% | 57.069% |
According to fenjal what are the pros and cons of Novo Nordisk A/S ADR for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by fenjal for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
fenjal stimmt dem Sentiment von 'Buy' zu
fenjal stimmt am 09.05.2017 dem Buy-Gesamtsentiment mit dem Kursziel 49.6€ zu.
(Vom Mitglied beendet)
Stopped prediction by fenjal for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€79.00
20.12.24
20.12.24
-
20.12.25
20.12.25
7.85%
10.01.25
10.01.25
Could be worthwhile Investment >10% per year
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€154.00
29.05.23
29.05.23
-
29.05.24
29.05.24
10.06%
16.08.23
16.08.23
Could be worthwhile Investment >10% per year


